Strategies to Protect Against Potential Bone-Destroying Effects
Chris D. Meletis, ND (with permission from cpmedical.net, access pin: 587556)
Gastroesophageal reflux disease (GERD), heartburn and acid indigestion are becoming some of the most common health complaints of our time. In fact, a new review of the medical literature found a significant trend for an increase in the prevalence of reflux symptoms in the general population over time, especially in the U.S., Singapore, and China.1
“If this trend continues,” the researchers wrote, “it could contribute to the rapidly increasing incidence of more serious complications associated with GERD, such as esophageal adenocarcinoma [cancer], as well as costs to healthcare systems and employers.”
The standard treatment for GERD and acid reflux is proton-pump inhibitors known by the brand names Aciphex(r), Nexium(r), Prevacid(r), Prilosec(r) (called Losec(r) in Europe), and Protonix(r). These pharmaceuticals work by inhibiting the generation of acid-ions known as protons.
